BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30165501)

  • 1. Deprescribing: the emerging evidence for and the practice of the 'geriatrician's salute'.
    Hilmer SN; Gnjidic D
    Age Ageing; 2018 Sep; 47(5):638-640. PubMed ID: 30165501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deprescribing medications in older people: a narrative review.
    Salahudeen MS
    Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
    Reeve E; Moriarty F; Nahas R; Turner JP; Kouladjian O'Donnell L; Hilmer SN
    Expert Opin Drug Saf; 2018 Jan; 17(1):39-49. PubMed ID: 29072544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing?
    Djatche L; Lee S; Singer D; Hegarty SE; Lombardi M; Maio V
    J Clin Pharm Ther; 2018 Aug; 43(4):550-555. PubMed ID: 29682764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swimming Against the Tide: Primary Care Physicians' Views on Deprescribing in Everyday Practice.
    Wallis KA; Andrews A; Henderson M
    Ann Fam Med; 2017 Jul; 15(4):341-346. PubMed ID: 28694270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Care Practitioners' Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults.
    Kouladjian L; Gnjidic D; Reeve E; Chen TF; Hilmer SN
    Ann Pharmacother; 2016 Aug; 50(8):625-36. PubMed ID: 27257284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a hospital deprescribing implementation framework: A focus group study with geriatricians and pharmacists.
    Scott S; Twigg MJ; Clark A; Farrow C; May H; Patel M; Taylor J; Wright DJ; Bhattacharya D
    Age Ageing; 2019 Dec; 49(1):102-110. PubMed ID: 31711097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing: A simple method for reducing polypharmacy.
    McGrath K; Hajjar ER; Kumar C; Hwang C; Salzman B
    J Fam Pract; 2017 Jul; 66(7):436-445. PubMed ID: 28700758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deprescribing considerations for older people in general practice.
    Quek HW; Page A; Potter K; Etherton-Beer C
    Aust J Gen Pract; 2023 Apr; 52(4):173-180. PubMed ID: 37021442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation.
    Lavan AH; Gallagher P; Parsons C; O'Mahony D
    Age Ageing; 2017 Jul; 46(4):600-607. PubMed ID: 28119312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A-TAPER: A Framework for Deprescribing Medications effectively.
    Armistead LT; Sanders KA; Larson CK; Busby-Whitehead J; Ferreri SP
    Res Social Adm Pharm; 2022 Aug; 18(8):3358-3361. PubMed ID: 34930683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults.
    Goyal P; Anderson TS; Bernacki GM; Marcum ZA; Orkaby AR; Kim D; Zullo A; Krishnaswami A; Weissman A; Steinman MA; Rich MW
    J Am Geriatr Soc; 2020 Jan; 68(1):78-86. PubMed ID: 31509233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deprescribing practices, habits and attitudes of geriatricians and geriatricians-in-training across Europe: a large web-based survey.
    van Poelgeest EP; Seppala LJ; Lee JM; Bahat G; Ilhan B; Lavan AH; Mair A; van Marum RJ; Onder G; Ryg J; Fernandes MA; Garfinkel D; Guðmundsson A; Hartikainen S; Kotsani M; Montero-Errasquín B; Neumann-Podczaska A; Pazan F; Petrovic M; Soulis G; Vankova H; Wehling M; Wieczorowska-Tobis K; van der Velde N;
    Eur Geriatr Med; 2022 Dec; 13(6):1455-1466. PubMed ID: 36319837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deprescribing in older people.
    Page AT; Potter K; Clifford R; Etherton-Beer C
    Maturitas; 2016 Sep; 91():115-34. PubMed ID: 27451330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review.
    Sawan M; Reeve E; Turner J; Todd A; Steinman MA; Petrovic M; Gnjidic D
    Expert Rev Clin Pharmacol; 2020 Mar; 13(3):233-245. PubMed ID: 32056451
    [No Abstract]   [Full Text] [Related]  

  • 17. Views of medical practitioners about deprescribing in older adults: Findings from an Italian qualitative study.
    D'Avanzo B; Agosti P; Reeve E; Pasina L; Sabbà C; Mannucci PM; Nobili A
    Maturitas; 2020 Apr; 134():29-33. PubMed ID: 32143773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.
    Todd A; Jansen J; Colvin J; McLachlan AJ
    BMC Geriatr; 2018 Nov; 18(1):295. PubMed ID: 30497404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines.
    Farrell B; Richardson L; Raman-Wilms L; de Launay D; Alsabbagh MW; Conklin J
    Res Social Adm Pharm; 2018 Jan; 14(1):18-25. PubMed ID: 28214150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frailty, polypharmacy and deprescribing.
    Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.